Pharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading ...
Source LinkPharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading ...
Source Link
Comments